Skip to main content
Clinical Trials/NCT00157144
NCT00157144CompletedNot Applicable

Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

Bayside Health1 site in 1 countryStarted: October 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Locations
1

Study Overview

Brief Summary

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice.

This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients receiving ECMO in Australia and New Zealand

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Bayside Health
Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials